• > Meet the Team
  • > Novel materials for renewable energy storage technologies
  • Case Studies - How our clients have used synchrotron light in their research
  • > Industrial applications and feedback from our users
  • > Combining Research Techniques for Effective Catalyst Design

Synchrotron Services for Industrial Scientists

Welcome to the Industrial Liaison Office. We are a group of specialist scientists with a diverse range of expertise, all dedicated to supporting scientists and researchers from a variety of industries access the facilities here at Diamond. The team has an assorted range of backgrounds and each member is a specialist in a different technique. We are therefore able to provide a multi-disciplinary approach to solving research and development problems.

To find out more about how we can help with your project, please select from the following options:

Alternatively you can search by the technique you are interested in, the industry sector you are from or simply find out more about the service we can offer by clicking one of the links below.



Featured Case Studies

Personalising alendronate therapy when treating Osteoporosis

The Problem profilephoto

Osteoporosis is a bone disease that affects 200 million people worldwide and contributes to 8.9 million fractures annually. The condition causes a loss of bone mass and structure which in turn leads to bones becoming weak and breaking, usually during a trip or fall. The disease is prevalent in people over 55, and in particular women, due to the loss of oestrogen hormone during the menopause. Osteoporosis is becoming increasingly prevalent in men who receive cancer therapies which supress testosterone levels. Bisphosphonates are a family of medicines which are commonly prescribed to treat osteoporosis. The most common types are alendronate and zoledronate which aim to strengthen osteoporotic bones by slowing down the activity of bone cells.


New discovery in malaria life-cycle

The Problem profilephoto

Malaria is one of the most prevalent parasitic diseases of humans and affects 216 million people worldwide. Many years of research have been dedicated to finding the most effective and affordable drugs to prevent infection, which have to date been very successful.  Most recently the challenge has been the growth in resistance to existing treatments, which has driven further research into a new generation of anti-malarial drugs.


Want to know more?

  Make an enquiry

  Join our mailing list

  Meet the team


Industrial Liaison Group:
Tel: +44 (0) 1235 778797

 Follow us on LinkedIn

Where to meet us next

Take a look at our event schedule for further details.

Latest News Subscribe to our newsfeed